JANE NGUYEN: Open Payments
NPI 1821455767 · ANAHEIM, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$817 in 12 payments from 8 companies in 2025. Trend: 2023 $125 · 2024 $308 · 2025 $817
Food & beverage: $817
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 1 | $147 |
| Otsuka America Pharmaceutical, Inc. | 1 | $143 |
| Teva Pharmaceuticals USA, Inc. | 1 | $128 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $125 |
| Corcept Therapeutics | 1 | $121 |
| Saluda Medical Americas, Inc. | 4 | $76 |
| Merz Pharmaceuticals, LLC | 2 | $45 |
| SANOFI PASTEUR INC. | 1 | $31 |
Products named: REPATHA, AUSTEDO XR, XIFAXAN, Korlym, Evoke, Xeomin, BEYFORTUS.
Industry payments across CA — which companies pay providers there.
